Linda P. Fried, MD, MPH (Co-Chair) is the dean of Columbia University’s Mailman School of Public Health and a leader in the fields of epidemiology and geriatric medicine. Since 2006, she has served as a member of the Aging Society Network, an international MacArthur Foundation think tank whose purpose is to create a roadmap to a successful society of longer lives. She has proposed the concept of a Third Demographic Dividend that enables society and individuals of all ages to experience the benefits of our now-longer lives, based on innovation in design of society’s environments and roles for older adults. She has served as the principal investigator (PI) for major longitudinal cohort studies, including the Cardiovascular Health Study (1989– 2008; National Heart, Lung, and Blood Institute [NHLBI]) and the Women’s Health and Aging Studies I (1990–2008; National Institute on Aging [NIA]) and II (1993–2008; NIA). She received the National Institutes of Health (NIH) MERIT Award to determine the pathophysiology of frailty (1998–2008; NIA) and served as the director of the Johns Hopkins Functional Status Laboratory (1987–1995). She has also served as the PI of NIH-funded randomized controlled trials, including the Goals for Eating and Moving trial of gingko biloba (NHLBI). She is the codesigner of AARP’s Experience Corps and coled the initial national and Baltimore-based implementation and evaluation. At Johns Hopkins, she served as the director of the Center on Aging and Health, the director of the Division of Geriatric Medicine, and the director of the Training Program in the Epidemiology and Biostatistics of Aging. She was also founding PI of the Johns Hopkins Older Americans Independence Center (Pepper Center; NIA) and co-PI of the NIA-funded Demography of Aging Center. She chaired the Johns Hopkins University President’s Task Force on the Status of Women in Academic Medicine.

Dr Mary Ann Tsao is the Chairwoman and Founding Director of the Tsao Foundation, a Singapore-based, but regionally oriented non-profit operational foundation dedicated to aged care and ageing issues. Previously, she was also its CEO and President.

Established by her grandmother in 1993, the Foundation is a leader in community-based eldercare. A long-standing advocate for older people, Tsao Foundation’s vision is that of an inclusive society for all ages that optimises opportunities in longevity. It aims to address issues of population ageing, promote successful ageing, and enhance wellbeing of older people at policy and practice levels by catalysing constructive change.

Through its five major initiatives – the Hua Mei Centre for Successful Ageing, Hua Mei Training Academy, International Longevity Centre Singapore, Initiative in Productive Longevity, and Community for Successful Ageing (ComSA) – the Tsao Foundation pioneers and provides community-based, person-centred primary healthcare for adults aged 40 and above; builds capacity in professional and informal aged care and self-care; fosters elder empowerment and community development; addresses issues of work and older adults; and forges cross-sector partnerships to initiate policy- relevant research, ideas, and approaches to actualising health, wellness, and participation over the life course.

Dr Tsao is also the current Chairwoman of the Tsao Family Office, the family investment office of a group of companies that started in shipping and led to the formation of the IMC Group. The Tsao Family Office aspires to deploy all its assets for impact through how they invest as well as philanthropy. She is currently also the Vice Chair for the newly established Tsao family foundation.

Dr Tsao has worked with multilateral agencies, such as WHO’s Geneva office and UNESCAP, and served on various government committees as well as non-profit boards in Singapore and internationally. She was a former Board Director for Family Business Network (FBN) Asia and is currently a member of FBN Asia’s Ambassador Circle.

For her work on ageing, Mary Ann has been recognised by the Singaporean Government as a recipient of the Public Service Medal, Public Service Star, and Public Service Star (Bar). A US-trained paediatrician with a public health background, she has extensive experience working with disadvantaged communities.

Professor Tan Chorh Chuan is both Executive Director of MOH Office for Healthcare Transformation (MOHT) and the Chief Health Scientist at MOH. He served as the Director of Medical Services at MOH from 2000 to 2004, where he was responsible for leading the public health response to the 2003 SARS epidemic.

He currently serves as a Member of the Expert Committee on COVID-19 Vaccination and as Singapore’s representative on the COVAX Shareholders Council. He had also held positions of NUS Provost, then Senior Deputy President between the years of 2004 to 2008, before serving as President of NUS from 2008 to 2017. His recent awards include the Knight of the French Order of the Legion of Honour (Chevalier de la Légion d’Honneur) for his contributions in the areas of health and science, especially during the COVID-19 pandemic. Professor Tan was also conferred the Distinguished Service Order, one of Singapore's top national honours, for his contributions to the country over the years.

He was awarded the National Science and Technology Medal in 2008 and is the first Singaporean to be elected as an international member of the US National Academy of Medicine.

A renal physician, Professor Tan obtained his medical training at NUS, and research training at the Institute of Molecular Medicine, Oxford.

John Beard, MD, PhD works globally with academia, policy makers, and the private sector to reimagine the second half of life. He is a professor with the University of New South Wales, the chief advisor for the European Institute of Innovation and Technology Health consortium (EIT Health), and a visiting professor at Toulouse and Peking universities. He also has a number of private-sector appointments. From 2009 to 2019, he was the director of aging and life course with the World Health Organization (WHO) in Geneva, serving as the editor and author for the World Report on Ageing and Health, which formed the basis for the 2016 Global Strategy and Action Plan on Ageing and Health that provides a political mandate for global action. In 2012, he established the WHO Global Network of Age-friendly Cities and Communities, which now comprises more than 1,000 cities and countries covering more than 250 million people. Other projects developed by his team include the Integrated Care for Older People program, a global campaign to combat ageism and reframe the way we think about aging and older age, and to work with research partners to identify and fill the many knowledge gaps in the field of aging. He was the coeditor of the 2014 Lancet series on aging. Prior to joining WHO, he held a range of senior public health and academic roles in Australia and the United States. He remains actively involved in several large international research projects on healthy aging.

Hiroki Nakatani, MD, MHPed, PhD is currently a visiting professor at the Keio University School of Medicine. He has also served as an invited professor at the Osaka University Graduate School of Medicine and in various national and international organizations, including as the chair of the board of directors, Global Health Innovative Technology Fund; as a senior advisor, Economic Research Institute for the Association of Southeast Asian Nations and East Asia; and as the hub director of population aging, Association of Pacific Rim Universities. He has been a public health specialist for more than 40 years, having started his career at the Ministry of Health, Labour, and Welfare in Japan. He has worked extensively in health policy, public health, international health, and health science and technology. His national career includes serving as the director-general of health and welfare services in Hiroshima Prefecture, where he was in charge of integrating health and welfare services in preparation for the arrival of a rapidly aging society. He joined the World Health Organization (WHO) headquarters as policy analyst in the Department of Human Resources for Health. In March 2007, he was appointed as the assistant director-general of WHO, leading the largest technical cluster on HIV/AIDS, Tuberculosis, Malaria, and Neglected Tropical Diseases. During his tenure, the morbidity and mortality of the three significant infections showed decline trends, and a few tropical diseases (dracunculiasis or guinea worm disease) were on track toward elimination and even eradication. After his retirement from WHO in May 2015, he has continued to serve the organization as a member of the WHO Executive Board, serving as the chair of the board from 2019 to 2020, and as a member of various oversight and advisory committees.

John Piggott, PhD is the director of the Australian Research Council’s Centre of Excellence in Population Ageing Research and the Australian Institute for Population Ageing Research at the University of New South Wales (UNSW), where he is the Scientia Professor of Economics. He has held a range of academic management positions at UNSW, including two terms as the head of economics and 7 years as the associate dean of research, and he served for more than 1 year as the interim dean of the Faculty of Commerce and Economics. In 2016, he was reelected as a member of the University’s Council. He has a long-standing interest in retirement and pension economics and finance. His publications include more than 100 journal articles and chapters in books, and he has also coauthored two books, both published by Cambridge University Press. In 2016, he coedited two volumes on aging: Handbook of the Economics of Population Ageing and Population Ageing and Australia’s Future. He serves as the book review editor of the Journal of Pension Economics and Finance, as an associate editor of the Journal of the Economics of Ageing, and as a member of the editorial board of the Journal of Retirement. His Australian policy experience includes membership on both the Henry Tax Review Panel and the Ministerial Superannuation Advisory Committee. Internationally, he has worked with the governments of Japan, Russia, and Indonesia on pension and aging issues, and in 2004, he was tasked with evaluating assistance on pension reform in the Asia region for the World Bank’s Operations Evaluation Department. In 2007, he was appointed as a visiting professor at Zhejiang University, China, and from 2008 to 2010 was a visiting scholar with the Department of Insurance and Risk Management at the University of Pennsylvania Wharton School of Business.

Yaohui Zhao, PhD is a professor of economics at the China Center for Economic Research of Peking University. Her research focuses on labor market issues in China, including determinants and consequences of rural-to-urban labor migration, wage differentials, and returns to education. Recently, she has begun to conduct research in the economics of health and aging, such as the socioeconomic status gradients of health, underdiagnoses of chronic diseases among the older population, and labor supply and living arrangements for older people. Since 2007, she has been the principal investigator of the China Health and Retirement Longitudinal Study, with a nationally representative sample of Chinese residents aged 45 and older. She received a B.A. and an M.A. from Peking University and a Ph.D. from the University of Chicago.

Dr. Srinivas Tata is the Director of the Social Development Division of ESCAP. He has 15 years of experience of working with the United Nations. As the head of the Social Development Division, his responsibilities include supporting member States in the promotion of social protection, fostering gender equality, and strengthening social inclusion of persons with disabilities, older persons, youth and migrants, among others. He is a physician by qualification with experience in social policy, public health and programme management.

He has served in wide range pf positions within the United Nations. He has previously served as the Chief of the Capacity Development and Partnerships Section of the Strategy and Programme Management Division, providing support to all ESCAP Divisions and Offices for the formulation and implementation of technical cooperation projects and managed partnerships with a wide range of stakeholders. He also served as the Chief of Social Policy and Population Section in the Social Development Division from 2012 to 2016, focusing on population ageing, demographic change, migration and health. He was also posted as the Deputy Chief of the Regional Commissions New York Office from 2010 to 2012.

Prior to joining the UN, he was posted as Director (Public Health) in the Ministry of Health in the Government of India, dealing with financing and implementation of large health programmes, and policies involving affordable access to medicines. He also worked in the Central Ministry of Finance dealing with indirect taxation policy and tariffs on a range of commodities.

Wendy Walker is the Chief of the Sustainable Development Thematic Group at the Asian Development Bank and currently co-leads the implementation of ADB Strategy 2030's first operational priority on Addressing Remaining Poverty and Reducing Inequalities. She provides technical leadership in social development and social protection and facilitates collaboration across sector and technical groups in ADB and with external partners. Wendy has worked to develop a focus on aging and long-term care in ADB operations and technical assistance programs. She is a team leader for technical assistance programs on Strengthening Capacity for Developing Members Capacity in Elderly Care and Developing Innovative Community-Based Long-Term Care Systems and Services in the region.

Mr Tan Meng Dui was appointed Chief Executive Officer of Housing & Development Board (HDB) on 26 February 2021. Before becoming CEO HDB, Meng Dui was the CEO of National Environment Agency (NEA), the leading public organisation responsible for ensuring a clean and green environment, and the sustainable development of Singapore. The two positions in HDB and NEA complement each other well. Both statutory boards belong to the Infrastructure and Environment cluster, and they play key roles in shaping the quality of the living environment, and in making Singapore a liveable, sustainable and endearing home that all Singaporeans can be proud of.

Meng Dui was previously the Deputy Secretary (Development) in the Ministry of National Development (MND) from 2014 to 2018. In this capacity, he was responsible for the development of Singapore’s public housing policies, as well as the research, corporate and communications strategies of the MND family. Before assuming his appointment in MND, Meng Dui was the Deputy Secretary (Technology) in the Ministry of Defence (MINDEF) from 2011 to 2014, and had earlier served in the Singapore Armed Forces (SAF) and Republic of Singapore Airforce (RSAF) where he started his career.

Meng Dui graduated from the Imperial College London with a Bachelor of Science in Mathematics in 1989. He has a Masters in Public Administration from Harvard University, and attended the Advanced Management Programme at the Wharton School, University of Pennsylvania.

Meng Dui is an Administrative Service officer in the Singapore Public Service. He was awarded the Public Administration Medal (Silver) (Military) in 2006.

University studies in political science and international economics in the Netherlands and the USA. MSc in Economics at El Colegio de Mexico. Over 30 years’ experience in social and economic development, working with academia, governments and international organisations.

As an academic, Eduardo has been a lecturer in international economics at the University of Mexico and in 1997 was appointed as Research Fellow in the International Development Center (QEH) and in the Oxford Institute of Ageing of the University of Oxford. He has led on programmes, studies and research on population ageing in Asia.

Eduardo has performed in senior roles in international organisations in Latin America and Africa. For the last 20 years Eduardo has been in Asia, holding different directive positions in Laos, Vietnam and regionally. Currently, he is the Regional Representative for Asia Pacific for HelpAge International, overseeing partnerships throughout Asia and the Pacific. In the scope of his work is promotion of social and economic adaptation to the changing demographic structures and to population ageing. Eduardo has taken part, and frequently led, in several international conferences on the subject. These include policy development, knowledge and research on population ageing, climate change and population ageing, community-based programmes and supporting the voice of older people and their organisations towards ensuring that current and future older people can lead dignified, active, healthy and secure lives in sustainable environments.

Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of detecting, delaying, preventing and treating human aging and associated diseases. He is a Distinguished Professor in Biochemistry and Physiology at the Yong Loo Lin School of Medicine at National University Singapore and serves as Director of (1) the Centre for Healthy Longevity at the National University Health System, (2) the Healthy Longevity Translational Research Programme and (3) the Asian Centre for Reproductive Longevity and Equality at NUS Medicine. Collectively, NUS aging research seeks to demonstrate that longevity interventions can be successfully employed in humans to extend healthspan, the disease-free and highly functional period of life.

From 2010 to 2016, Dr. Kennedy was the President and CEO of the Buck Institute for Research on Aging and he maintained a professorship there through 2020. Dr. Kennedy has an adjunct appointment at the Department of Biochemistry at the University of Washington, where he was a faculty member from 2001 to 2010. In addition, Dr. Kennedy is also actively involved with a number of Biotechnology companies. In addition, Dr. Kennedy serves as a Co-Editor-In-Chief at Aging Cell. Finally, Dr. Kennedy has a track record of interaction in China, where he was a Visiting Professor at the Aging Research Institute at Guangdong Medical College from 2009 to 2014. His Ph.D. was performed in the laboratory of Leonard Guarente at M.I.T., where he published the first paper linking Sirtuins to aging.

Professor Guan is a President's Chair Professor in Computer Science and Engineering at Nanyang Technological University (NTU), Singapore. He is the Director of the Artificial Intelligence Research Institute (AI.R) of NTU. He is the Co-Director, S-Lab for Advanced Intelligence (S-Lab), NTU. He is the Director of the Centre for Brain-Computing Research (CBCR). He is on the Steering Committee of Ageing Research Institute for Society and Education (ARISE), NTU. He is a member of the Management Committee of the Singapore Health Technologies Consortium (HealthTEC), Singapore. He serves on the Advisory Board of the Elite Master Program in Neuroengineering, TUM, Germany. He serves as the Scientific Advisor of Neeuro Pte Ltd, Singapore. He is also a scientific advisor to several other companies. He initiated and served as the Co-Director of the Rehabilitation Research Institute of Singapore (RRIS), 2015-2018. Prior to joining NTU in 2016, he was the founding Department Head of the Neural & Biomedical Technology Department and Principal Scientist II (RSE6) at the Institute for Infocomm Research (I2R), Agency for Science, Technology, and Research (A*SATR), Singapore. He is a Fellow of the Singapore Academy of Engineering (SAEng), IEEE, and AIMBE.

His research interests are in the fields of Brain-Computer Interfaces (BCI), Machine Learning, Neural Signal & Image Processing, Data Analytics, and Artificial Intelligence. He published 7 book chapters, 370 refereed journal and conference papers, and holds 25 granted patents and patent applications. He licensed 15 patents/technologies to five companies in Singapore and USA. He delivered more than 70 keynote speeches and invited talks (including the keynote, Brain-Computer Interfaces for Stroke Rehabilitation, at the opening ceremony of the 7th International BCI Meeting, Asilomar, USA, May 2018). He is a recipient of the Annual BCI Research Award, the IES Prestigious Engineering Achievement Award, Achiever of the Year (Research) Award, Finalist of President Technology Award, and winner of BCI Competitions.

Ambassador Chan Heng Chee is Ambassador-at-Large with the Ministry of Foreign Affairs. She is Professor at the Lee Kuan Yew Centre for Innovative Cities in the Singapore University of Technology and Design.

She is a member of the Presidential Council for Minority Rights.

Ambassador Chan is Chairman, Board of Trustees, ISEAS – Yusof Ishak Institute (ISEAS) the premier multi-disciplinary research institute on Southeast Asia in the region. She is the Deputy Chairman of the Social Science Research Council and a Member of the Science of Cities Committee, (National Research Foundation).

Ambassador Chan is a Member of the Board of Trustees of the National University of Singapore and a Member of the Yale-NUS Governing Board. She is Chairman of Pro-tem committee to establish a university of the arts in Singapore.

She is Global Co-Chair of Asia Society. She sits on the governing board of the Stockholm International Peace Research Institute (SIPRI), Sweden.

Previously, she was Singapore’s Ambassador to the United States and Singapore’s Permanent Representative to the United Nations with concurrent accreditation as High Commissioner to Canada and Ambassador to Mexico.

Professor John Eu-Li WONG, Isabel Chan Professor in Medical Sciences, is currently Senior Vice President (Health Innovation and Translation), National University of Singapore (NUS) and Senior Advisor, National University Health System (NUHS).

A medical oncologist-haematologist, Professor Wong obtained his MBBS from NUS and did his residency and fellowship at the New York Hospital-Cornell Medical Center, where he was the Chief Resident in Medicine, and Memorial Sloan-Kettering Cancer Center.

He is currently co-chairing the Health District @ Queenstown: a whole-of-society initiative to work with residents in a location based, real-world township to co-develop programs that are effective, scalable and sustainable to increase healthy longevity, enable purposeful longevity, promote intergenerational bonding and support a community for all ages to allow ageing in place.

He was awarded the Degree of Doctor Philosophiae Honoris Causa from the Hebrew University of Jerusalem in 2019; Singapore National Day Awards 2016 - Public Administration Medal (Gold); Singapore’s President’s Science & Technology Medal in 2014; the Outstanding Service Award from the National University of Singapore in 2013; recognised by the NUS Medical Society in 2011 for his contributions to medical student education; the Singapore Medical Association Lecturer in 2010; the Sass Foundation Award in conjunction with MD Anderson Cancer Center in 2010; the National Outstanding Clinician Award in 2009 by the Ministry of Health; the Singapore National Day Awards 2005 - Public Administration Medal (Silver); and a Special Letter of Commendation from the Singapore Armed Forces in 1983. He is a Fellow of the Academy of Medicine Singapore, the Royal College of Physicians in Edinburgh and London, and the American College of Physicians. He was elected as an international member of the United States of America National Academy of Medicine in 2019, and a member of the Academia Europaea in 2022.

Victor J. Dzau, MD, is the President of US National Academy of Medicine (NAM) and Vice Chair of US National Research Council. He is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University. Previously, he was Professor and Chairman of Medicine at both Harvard and Stanford Universities. He is an internationally acclaimed leader and physician scientist who has made a significant impact through his seminal research in cardiovascular medicine. His research laid the foundation for development of the class of lifesaving drugs known as ACE inhibitors, used globally to treat high blood pressure and heart failure. He pioneered gene therapy for vascular disease. Dr Dzau serves as the inaugural president of NAM, transitioning from Institute of Medicine, and leads a strategy of innovation, action and equity. He designed and led important initiatives such as the Global Health Risk Framework; Human Genome Editing; Emerging Science, Technology and Innovation; Climate Change and Human Health. In 2019, NAM launched the Grand Challenge in Healthy Longevity which represents his vision to inspire across disciplines and sectors to transform health and society around global aging. The NAM Grand Challenge consists of Global Competition to catalyze transformative ideas and breakthrough innovations for healthy longevity internationally, and the Roadmap as an authoritative, international, evidence-based report that recommends effective solutions for healthy aging and longevity. He serves as co-chair of its International Oversight Board. Dr Dzau was on the Board of Health Governors of the World Economic Forum and chaired its Global Futures Council on Healthy Longevity. Among his many honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Poulzer Prize of the European Academy of Sciences and Arts, the Henry Freisen International Prize and Honorary Citizen of Singapore. He has received 16 honorary doctorates.